Showing 501 - 520 results of 21,515 for search '(( 5 ((step decrease) OR (teer decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 0.69s Refine Results
  1. 501
  2. 502
  3. 503

    Image 1_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”
  4. 504

    Table 1_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.docx by Francesca Bietto (21511316)

    Published 2025
    “…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”
  5. 505

    Image 4_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”
  6. 506

    Image 2_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”
  7. 507

    Image 3_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”
  8. 508
  9. 509

    SMNΔ7 NMJs display a decrease in synaptic efficacy. by Karen K. Y. Ling (237660)

    Published 2010
    “…There is an increase in MEPP amplitude, a decrease in MEPP frequency and a reduction in quantal content in SMNΔ7 mice (n = 100–130 NMJs from 7 control and 10 SMNΔ7 mice; ***<i>p</i><0.0001, ** <i>p</i> = 0.007). …”
  10. 510
  11. 511
  12. 512
  13. 513
  14. 514

    GBE decreased secretion of Aβ1-40 in APP cells. by Virginie Rhein (243241)

    Published 2010
    “…Secreted Aβ1-40 was significantly decreased in GBE-treated APP cells (100 µg/ml; 24 h). …”
  15. 515
  16. 516
  17. 517

    Decreased mitochondrial reactive oxygen species in Aβ resistant cells. by Jordan T. Newington (223389)

    Published 2011
    “…This decrease in ROS was maintained with 48 hr Aβ (20 µM) exposure. …”
  18. 518

    Inhibition of PSMA decreases pathologic angiogenesis in a mouse model of OIR. by Christina L. Grant (315488)

    Published 2013
    “…<p><b>A</b>) Wild type mice undergoing OIR were treated systemically with either a single dose of 100mg/kg 2-PMPA on P14 (n = 3, <b>center</b>) or three daily doses from P14 through P16 (n = 6, <b>right</b>), controls received vehicle (PBS, <b>left</b>). …”
  19. 519

    Phosphopeptides with predicted MAPK site that showed decreased abundance in 1NM-PP1-treated <i>mak-2<sup>Q100G</sup></i> cells. by Wilfried Jonkers (160931)

    Published 2014
    “…</p>3<p>Showed reduced expression in a <i>mak-2<sup>Q100G</sup></i> germlings treated with 1NM-PP1 (19).…”
  20. 520